FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileBLS Pharmaceuticals Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
BLS.AX
BLS Pharmaceuticals Limited Stock AnalysisComprehensive stock analysis for BLS Pharmaceuticals Limited (BLS.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBLS.AX
BLS.AX
BLS Pharmaceuticals Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
BLS.AX
  1. Home
  2. Stocks
  3. BLS Pharmaceuticals Limited
BL

BLS Pharmaceuticals Limited

🇦🇺BLS.AX•ASX
BL

BLS Pharmaceuticals Limited

🇦🇺BLS.AX•ASX
P/E ratio
24.23

Your view on BLS.AX

P/E
24.23
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About BLS Pharmaceuticals Limited

Industry
Specialty Business Services
Sector
Industrials
CEO
Sam Watson
Headquarters
Level 5, Sydney, NSW, AU
Industry
Specialty Business Services
Sector
Industrials
CEO
Sam Watson
Headquarters
Level 5, Sydney, NSW, AU
Description

BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia.

The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for BLS Pharmaceuticals Limited. Starting points for BLS Pharmaceuticals Limited: P/E 24.2, EPS AUD 0.04, beta 0.62 — an Specialty Business Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for BLS Pharmaceuticals Limited. BLS Pharmaceuticals Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for BLS Pharmaceuticals Limited. Trailing twelve-month EPS for BLS Pharmaceuticals Limited stands at AUD 0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for BLS Pharmaceuticals Limited. BLS Pharmaceuticals Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold BLS.AX20 companies
Compare BLS.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
BIO.AXBiome Australia LimitedHealthcareMedical - Pharmaceuticals—
BP8.AXBPH Global LtdHealthcareDrug Manufacturers - Specialty & Generic—
CSL.AXCSL LimitedHealthcareBiotechnology—
ECS.AXECS Botanics Holdings LtdHealthcareDrug Manufacturers - Specialty & Generic—
EXL.AXElixinol Wellness LimitedHealthcareDrug Manufacturers - Specialty & Generic—
LGP.AXLittle Green Pharma LtdHealthcareDrug Manufacturers - Specialty & Generic—
MYX.AXMayne Pharma Group LimitedHealthcareMedical - Pharmaceuticals—
S66.AXStar Combo Pharma LimitedConsumer DefensiveHousehold & Personal Products—
More Specialty Business Services companies
TickerTypeCompanySectorExchangeMkt cap
CSGUConsolidated Sports Media GroupIndustrialsOTC—
CTAGFCapita plcIndustrialsOTC$437.9M
CTAGYCapita plcIndustrialsOTC$7.2B
CTASCintas CorporationIndustrialsNASDAQ$88.2B
CTGLCitrine Global Corp.IndustrialsOTC$151.3M
CUP.AXCount LimitedIndustrialsASX—
CVEOCiveo CorporationIndustrialsNYSE$355.2M
CWPSConwest Associates, LPIndustrialsOTC—
DCM.TODATA Communications Management Corp.IndustrialsTSX$160.2M
DCMDFDATA Communications Management Corp.IndustrialsOTC$58.9M
DIV.TODiversified Royalty Corp.IndustrialsTSX$600.9M
DLHCDLH Holdings Corp.IndustrialsNASDAQ$41.3M
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of BLS Pharmaceuticals Limited.

BLS.AX AnalysisWeak
Past
5
Growth
0
Health
0
Profit
0
Value
0